We thus favor a model in which MLL2 inactivation, although likely not in itself essential for tumorigenesis (Issaeva et al. 2007), drives tumor evolution through the gains and losses of genomic regions and/or increased gene mutation; in other words, through a wave of genomic instability, particularly in active genes, fueling cancer evolution and heterogeneity. This evidence concerns the gene KMT2D and cancer.